The surgical removal of diseased tissue from the body and subsequent careful examination by histologic, biologic, and even chemical analyses has greatly enhanced our understanding of the etiology and pathophysiology of many disease entities. Furthermore, it has provided the clinician with a rational foundation for specific therapy, replacing regimens previously employed, many of which had been based solely on empirical principles. In recent years, the introduction of the Vim-Silverman or similar type biopsy needles, combined with the resurrection and reevaluation of needle aspiration techniques, has provided us with invaluable information especially in hepatic and renal disease. Smetana1 recently reviewed the experiences with specimens obtained by needle biopsy submitted for pathologic study and concluded that this procedure, properly and judiciously employed, has distinct advantages over many presently accepted diagnostic techniques. Since the first report of serous membrane needle biopsy, by DeFrancis,2 in 1955, others have reported more extensive studies
DONOHOE RF, SHNIDER BI, GORMAN J. Needle Biopsy of the Peritoneum: A Preliminary Report. AMA Arch Intern Med. 1959;103(5):739–745. doi:10.1001/archinte.1959.00270050061010
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: